CSF2 and neoplasm: A study by Hensel et al. showed that a combination of AAV1 vector expressing CEA and GM-CSF application was able to break tolerance to CEA and significantly improved tumor-free survival in a syngeneic MC38 mouse model compared to GM-CSF treatment with a control AAV vector [180].